Christopher J Delves

Title: **Innovator Spotlight: Christopher J. Delves**

Introduction

Christopher J. Delves, located in Stevenage, GB, is a notable inventor recognized for his contributions to the field of biochemistry. His innovative work has led to the development of a significant patent that showcases his expertise and creativity in modifying nuclear receptor polypeptides.

Latest Patents

Delves holds a patent titled "Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same." This patent describes a complex method of modifying a test nuclear receptor (NR) polypeptide. The process involves aligning a test NR polypeptide sequence with established reference sequences, building a three-dimensional model based on X-ray structures, and making targeted mutations to enhance the properties of the test NR polypeptide.

Career Highlights

Christopher J. Delves is affiliated with SmithKline Beecham Corporation, where he has been able to apply his knowledge and skills in the development of pharmaceutical innovations. His work is characterized by a commitment to advancing scientific research, particularly in the field of hormone receptor biology.

Collaborations

Throughout his career, Delves has collaborated with several noteworthy professionals in his field, including Christopher J. Apolito and Randy K. Bledsoe. These collaborations have likely contributed to the advancement of research and development at SmithKline Beecham Corporation, fostering innovative solutions in biochemistry.

Conclusion

Christopher J. Delves exemplifies the spirit of innovation within the scientific community. His patented methodologies not only reflect his dedication to research but also pave the way for future advancements in the understanding and utilization of nuclear receptors. As he continues his work, Delves remains a valuable contributor to the landscape of biochemistry and pharmaceutical innovation.